EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (Under Process) , 

 ISSN 2394-3211

Impact Factor: 4.897

 ICV - 79.57

Abstract

TNF ALPHA; A NOVEL TARGET FOR THE TREATMENT OF CANCER

Sonam Patel, Nidhi Mishra*, Agrima Srivastava, Shivam Yadav and Prabhat Kumar Yadav

ABSTRACT

Tumor nicrosis factor alpha (TNF-α), secluded 30 years back, is a multifunctional cytokine assuming a key job in apoptosis and cell survival just as in irritation and resistance. Despite the fact that named for its antitumor properties, TNF has been ensnared in a wide range of different ailments. The present utilization of TNF in malignant growth is in the provincial treatment of privately progressed delicate tissue sarcomas and metastatic melanomas and other irresectable tumors of any histology to keep away from removal of the appendage. It has been exhibited in the detached appendage perfusion setting that TNF-α acts synergistically with cytostatic drugs. The collaboration of TNF-α with TNF receptor 1 and receptor 2 (TNFR-1, TNFR-2) actuates a few flag transduction pathways, prompting the assorted elements of TNF-α. The flagging particles of TNFR-1 have been explained great, yet direction of the flagging stays vague. Other than these sub-atomic bits of knowledge, research center analyses in the previous decade have revealed insight upon TNF-α activity amid tumor treatment. Other than extravasation of erythrocytes and lymphocytes, prompting hemorrhagic putrefaction, TNF-α focuses on the tumor-related vasculature (TAV) by initiating hyperpermeability and annihilation of the vascular coating. This outcomes in a quick impact of specific amassing of cytostatic tranquilizes inside the tumor and a late impact of demolition of the tumor vasculature. In this survey, covering TNF-α from the particle to the center, we give a diagram of the utilization of TNF-α in malignant growth beginning with sub-atomic bits of knowledge into TNFR-1 flagging and cell components of the antitumor exercises of TNF-α and finishing with clinical reaction. Furthermore, conceivable variables balancing TNF-α activities are talked about.

Keywords: TNF alpha, anti-cancer, therapeutic novel targeted drug, gene therapy.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2019 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR MARCH ISSUE PUBLISHED

    MARCH 2019 Issue has been successfully launched on 1 March 2019

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 4.161 to 4.897 due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (Under Process)